Pharmacological study on a new analgesic-anti-inflammatory drug: alpha-(4-(1-oxo-2-iso-indolinyl)-phenyl)-propionic acid of K 4277.
D000276:Adjuvants, Immunologic; D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001920:Bradykinin / Q000037:antagonists & inhibitors; D001986:Bronchial Spasm / Q000188:drug therapy; D002415:Cats; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006168:Guinea Pigs; D006329:Heart Conduction System / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D010666:Phenylpropionates / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013950:Thymus Gland / Q000187:drug effects
D000276:Adjuvants, Immunologic; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D007211:Indoles; D010666:Phenylpropionates; D010653:Phenylbutazone; D001920:Bradykinin; D007213:Indomethacin